Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2,141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study.
Hamilton BK, Rybicki L, Haddad H, Abounader D, Yurch M, Majhail NS, Hanna R, Sobecks R, Dean R, Liu H, Hill B, Copelan E, Bolwell B, Kalaycio M. Hamilton BK, et al. Among authors: hill b. Blood Cancer J. 2015 Aug 28;5(8):e344. doi: 10.1038/bcj.2015.70. Blood Cancer J. 2015. PMID: 26314986 Free PMC article. No abstract available.
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
Hill BT, Rybicki L, Bolwell BJ, Smith S, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E, Sweetenham J. Hill BT, et al. Br J Haematol. 2011 Mar;152(5):561-9. doi: 10.1111/j.1365-2141.2010.08549.x. Epub 2011 Jan 12. Br J Haematol. 2011. PMID: 21223255 Free article.
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
Hill BT, Rybicki L, Smith S, Dean R, Kalaycio M, Pohlman B, Sweetenham J, Tench S, Sobecks R, Andresen S, Copelan E, Bolwell BJ. Hill BT, et al. Leuk Lymphoma. 2011 Jun;52(6):986-93. doi: 10.3109/10428194.2010.551154. Epub 2011 Feb 14. Leuk Lymphoma. 2011. PMID: 21314484
Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
Lukenbill J, Rybicki L, Sekeres MA, Zaman MO, Copelan A, Haddad H, Fraser T, DiGiorgio MJ, Hanna R, Duong H, Hill B, Kalaycio M, Sobecks R, Bolwell B, Copelan E. Lukenbill J, et al. Among authors: hill b. Biol Blood Marrow Transplant. 2013 May;19(5):720-4. doi: 10.1016/j.bbmt.2013.01.022. Epub 2013 Feb 1. Biol Blood Marrow Transplant. 2013. PMID: 23380342 Free article.
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.
Hamilton BK, Bolwell B, Kalaycio M, Rybicki L, Hanna R, Sobecks R, Pohlman B, Andresen S, Dean R, Duong H, Hill B, Copelan E. Hamilton BK, et al. Among authors: hill b. Bone Marrow Transplant. 2013 Nov;48(12):1578-80. doi: 10.1038/bmt.2013.89. Epub 2013 Jun 10. Bone Marrow Transplant. 2013. PMID: 23749105 Clinical Trial. No abstract available.
2,141 results